Clinicopathologic characteristics and outcomes of gastric cancers with the MSI‐H phenotype
Authors:
- 30 December 2008
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 99 (3) , 143-147
Abstract
Objectives: We examined the correlation between microsatellite instability (MSI) status and the clinicopathological features and prognostic value in gastric cancer and compared the efficacy of immunohistochemical staining for hMLH1 and hMSH2 with a polymerase chain reaction (PCR)‐based test.Methods: MSI status was examined in 328 consecutive gastric adenocarcinomas using tissue preserved in paraffin blocks. DNA extracted from tumor sections and the corresponding normal tissue was analyzed using PCR at the five microsatellite loci recommended by the National Cancer Institute (NCI). Immunohistochemical staining for hMLH1 and hMSH2 was performed and the results were compared with the MSI status measured using PCR. The relationship of the clinicopathologic variables to MSI status was analyzed.Results: Of the gastric cancers, 8.2% (n = 27) contained MSI‐H and this was associated with older age (>70 years), distal tumor location, tumor size, and intestinal subtype. Lymphatic and vascular invasion were associated with the disease‐free survival. On immunohistochemical staining, the loss of expression of hMLH1 or hMSH2 was observed in 11% (n = 36). The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of immunohistochemical staining were 63.0%, 93.7%, 47.2%, 96.6%, and 91.2%, respectively.Conclusions: Gastric cancers with MSI‐H have specific clinicopathologic characteristics, such as older age at diagnosis, distal tumor location, increased tumor size, and intestinal histologic type. However, immunohistochemical staining for hMLH1 and hMSH2 is not as accurate as the PCR‐based MSI test. J. Surg. Oncol. 2009;99: 143–147.Keywords
This publication has 25 references indexed in Scilit:
- High-resolution fluorescent analysis of microsatellite instability in gastric cancerEuropean Journal of Gastroenterology & Hepatology, 2007
- Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancersSurgery, 2006
- Microsatellite instability is linked to loss of hMLH1 expression in advanced gastric cancers: lack of a relationship with the histological type and phenotypeGastric Cancer, 2005
- Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of ageBritish Journal of Surgery, 2003
- Distinct Clinical Features and Outcomes of Gastric Cancers with Microsatellite InstabilityLaboratory Investigation, 2002
- Molecular and Clinical Characteristics of MSH6 Variants: An Analysis of 25 Index Carriers of a Germline VariantThe American Journal of Human Genetics, 2002
- Features of Colorectal Cancers with High-Level Microsatellite Instability Occurring in Familial and Sporadic SettingsThe American Journal of Pathology, 2001
- Microsatellite alterations and target gene mutations in the early stages of multiple gastric cancerThe Journal of Pathology, 2001
- Tumor Microsatellite Instability and Clinical Outcome in Young Patients with Colorectal CancerNew England Journal of Medicine, 2000
- Origin of Microsatellite Instability in Gastric CancerThe American Journal of Pathology, 1999